학술논문
FDA postmarketing safety labeling changes: What have we learned since 2010 about impacts on prescribing rates, drug utilization, and treatment outcomes
Document Type
Article
Author
Source
In: Pharmacoepidemiology and Drug Safety . (Pharmacoepidemiology and Drug Safety, 1 September 2020, 29(9):1022-1029)
Subject
Language
English
ISSN
10991557
10538569
10538569